Iterum Therapeutics PLC (ITRM) — 10-Q Filings
All 10-Q filings from Iterum Therapeutics PLC. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Iterum's ORLYNVAH Launch Fails to Stem Mounting Losses, Cash Dwindles
— Nov 14, 2025 Risk: high
Iterum Therapeutics plc reported a net loss of $8.979 million for the three months ended September 30, 2025, an increase from a net loss of $6.094 million in th -
Iterum Therapeutics Files Q1 2025 10-Q
— May 13, 2025 Risk: medium
Iterum Therapeutics plc filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operati -
Iterum Therapeutics Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Iterum Therapeutics plc filed a 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third qu -
Iterum Therapeutics 10-Q Filed
— Aug 14, 2024 Risk: medium
Iterum Therapeutics plc filed its 10-Q for the period ending June 30, 2024. The company reported on its financial condition, including its cash position and any -
Iterum Therapeutics plc Files 10-Q for Period Ending March 31, 2024
— May 13, 2024 Risk: medium
Iterum Therapeutics plc (ITRM) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Iterum Therapeutics plc filed a 10-Q report for the period ending M
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX